BioTech Medics, Inc. Engages New Chartered Accountants
DALLAS, April 26, 2006 /PRNewswire-FirstCall via COMTEX/ -- The Board of Directors of BioTech Medics, Inc. (OTC Pink Sheets: BTMD) announced that the company has signed an Engagement Letter with Moore and Associates, Chartered Accountants of 2675 South Jones Blvd., Suite 109, Las Vegas, Nevada 89146 ("Moore").
Moore has initially been retained as BioTech's independent accountant for the compilation of the fiscal year ending December 31, 2005 and first quarter of 2006. The compilation is for the purpose of BioTech filing Form 211 with issuer information and disclosure statements pursuant to Rule 15C2-11(A)(5) promulgated under the SECURITIES & EXCHANGE ACT OF 1934, AS AMENDED, and is intended only as information to be used by securities broker-dealers in compliance with NASD regulations.
Keith Houser, CEO of BioTech, stated: "We filed our Form 211 last year with NASD, but the filing was not accepted as complete by NASD as BioTech's Financial Statements were not 'compiled by an accountant'. This year BioTech Medics, Inc. intends to file again with 'compiled financial statements' by the Moore accounting firm. Should the filing be accepted by NASD, BTMD will be eligible to be quoted on the Pinksheets again. We subsequently will have the CPAs complete our audit so that BTMD can be a fully reporting company."
Previously, BioTech had engaged the CPA firm of Bagell, Josephs and Co, LLC of New Jersey. This CPA firm completed Corbel IRS Filings through December, 2004.
BioTech Medics is a distributor of the NeuroLase Therapeutic Medical Laser, SHBAN Solution and operates Pain Management & Wellness Centers. The Neurolase provides non-invasive drug-free relief from muscular, skeletal and arthritic pain.
On the Web at: biotechmedics.com
Contact: Keith Houser, CEO 972-274-5533
SOURCE BioTech Medics, Inc.
CONTACT: Keith Houser, CEO of BioTech Medics, Inc., +1-972-274-5533
URL: prnewswire.com
biotechmedics.com
. |
